Skip to Main Content

Paper Details

Community-driven development of a modified progression-free survival ratio for precision oncology.
ESMO Open
19
2019
Cancer, Tumor, participants, patient, patients
Author NameAffiliation
Simon KreutzfeldtNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Simon Kreutzfeldt
Benedikt Brors
Benedikt Brors
Benedikt Brors
Benedikt Brors
Albrecht Stenzinger
Albrecht StenzingerInstitute of Pathology, Heidelberg University Hospital
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Stefan Fr??hling
Peter HorakNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Peter Horak
  • 1 - 12

Datasets

Release 1.2